One critically important regulatory action of the NF-kB complex is to upregulate a small family of pathogenic miRNAs in the brain and CNS, which in turn targets and downregulates a group of mRNAs whose downregulation is decisive in driving the neuropathology of AD (Table 1). This evidence concerns the gene NFKB1 and Alzheimer disease.